Singular Genomics Systems, Inc. (OMIC)
Largest Insider Buys in Sector
OMIC Stock Price History Chart
OMIC Stock Performance
About Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile …
Insider Activity of Singular Genomics Systems, Inc.
Over the last 12 months, insiders at Singular Genomics Systems, Inc. have bought $1.81M and sold $21,465 worth of Singular Genomics Systems, Inc. stock.
On average, over the past 5 years, insiders at Singular Genomics Systems, Inc. have bought $8.82M and sold $191,725 worth of stock each year.
Highest buying activity among insiders over the last 12 months: TANG KEVIN (10 percent owner) — $3.61M.
The last purchase of 32,000 shares for transaction amount of $550,720 was made by TANG KEVIN (10 percent owner) on 2024‑09‑18.
List of Insider Buy and Sell Transactions, Singular Genomics Systems, Inc.
| 2024-12-16 | Sale | Chief Executive Officer | 180 0.0072% | $20.16 | $3,629 | -2.19% | ||
| 2024-11-12 | Sale | Chief Executive Officer | 695 0.0273% | $22.55 | $15,669 | -7.23% | ||
| 2024-09-18 | 10 percent owner | 32,000 1.3143% | $17.21 | $550,720 | +16.91% | |||
| 2024-09-17 | 10 percent owner | 40,000 1.5204% | $15.33 | $613,200 | +20.98% | |||
| 2024-09-16 | 10 percent owner | 50,416 2.0091% | $12.74 | $642,300 | +52.03% | |||
| 2024-09-15 | Sale | Chief Executive Officer | 175 0.007% | $12.38 | $2,167 | +13.08% | ||
| 2023-11-17 | Chief Executive Officer | 75,000 0.1012% | $0.42 | $31,755 | -3.96% | |||
| 2023-11-16 | Chief Scientific Officer | 200,000 0.272% | $0.43 | $85,640 | -1.18% | |||
| 2023-11-16 | Chief Executive Officer | 43,468 0.0567% | $0.41 | $17,857 | -1.18% | |||
| 2023-08-15 | Sale | director | 200,000 0.2773% | $0.53 | $106,960 | -24.02% | ||
| 2023-08-14 | Sale | director | 77,991 0.1139% | $0.57 | $44,424 | -24.82% | ||
| 2023-08-11 | Sale | director | 353,657 0.5041% | $0.60 | $210,603 | -29.80% | ||
| 2023-05-17 | Chief Scientific Officer | 170,000 0.2422% | $0.82 | $138,924 | -41.05% | |||
| 2022-12-12 | Chief Scientific Officer | 50,000 0.0743% | $2.00 | $100,000 | -53.90% | |||
| 2022-05-18 | 26,834 0.0412% | $3.30 | $88,552 | -19.74% | ||||
| 2021-06-01 | 10 percent owner | 1.5M 3.3473% | $22.00 | $33M | -62.91% |
Insider Historical Profitability
| TANG KEVIN | 10 percent owner | 372000 14.8102% | $19.55 | 3 | 0 | |
| Spaventa Andrew | Chief Executive Officer | 631 0.0251% | $19.55 | 2 | 3 | |
| Flynn James E | 10 percent owner | 7484871 297.9907% | $19.55 | 1 | 0 | <0.0001% |
| Glezer Eli N. | Chief Scientific Officer | 4570000 181.9427% | $19.55 | 3 | 0 | <0.0001% |
| Pellini Michael J | 99289 3.9529% | $19.55 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Deerfield Management | $2.56B | 201.84 | 4.98M | 0% | +$0 | 6.25 | |
| Arch Venture Management Llc | $1.95B | 153.82 | 3.8M | 0% | +$0 | 96.36 | |
| Qvidtvm Management Llc | $1.29B | 101.5 | 2.51M | +8.06% | +$96.18M | 91.29 | |
| UBS | $1.14B | 89.46 | 2.21M | +<0.01% | +$16,962.00 | 0.34 | |
| Perceptive Advisors | $1.09B | 86.12 | 2.13M | 0% | +$0 | 0.7 |